pyridoxal-4-methoxybenzoyl-hydrazone and pyridoxal-isonicotinoyl-hydrazone

The ultraviolet-visible absorption spectra of the orally effective iron chelator, pyridoxal isonicotinoly hydrazone (PIH), and three analogues, pyridoxal benzoyl hydrazone (PBH), pyridoxal p-methoxybenzoyl hydrazone (PpMBH) and pyridoxal m-fluorobenzoyl hydrazone (PmFBH) have been measured in aqueous solution with various concentrations of added acid or alkali. Assignment of absorption bands to various molecular species in equilibrium in aqueous solution is made by reference to their acid ionisation constants. All four hydrazones were stable at physiologial pH, but hydrolysed in strongly acidic and basic solutions, resulting in the liberation of pyridoxal and the acid hydrazide. In acidic solutions this resulted in a dramatic decrease in the intensity of absorption at wavelengths of 225 nm and above 300 nm, allowing a quantitative estimate of the degree of acid-catalysed hydrolysis of the ligands. These results indicate that for oral administration the chelator should be administered with calcium carbonate or provided with an enteric coating to minimise acid-catalysed hydrolysis in the stomach. At high pH, base-catalysed hydrolysis occurred, resulting in a decrease in the absorption at a wavelength of 387 nm.

Topics: Drug Stability; Hydrazones; Hydrogen-Ion Concentration; Hydrolysis; Iron Chelating Agents; Isoniazid; Pyridoxal; Solutions; Spectrophotometry; Spectrophotometry, Ultraviolet